News & Updates
Showing Neurology articles
Showing

AChEIs and memantine cost-effective, offer improvements in AD
A systematic review and meta-analysis of Alzheimer’s disease (AD) therapies’ cost-effectiveness carried out by researchers from the Chinese University of Hong Kong (CUHK) identifies acetylcholinesterase inhibitors (AChEIs) and memantine as cost-effective and offering improvements in dementia-related symptoms.

Physical activity associated with intact cognition after mild or moderate stroke
A Swedish register-based study finds that patients who engage in light or moderate physical activity are more likely to retain their cognitive function after a mild or moderate stroke vs inactive counterparts.

One in 10 patients fully recover from consciousness disorders after severe COVID-19
Among patients who suffer from disorders of consciousness (DoC) after severe COVID-19, around 10 percent can achieve functional independence after 1 year, reports a study presented at the recently concluded 2022 Annual Meeting of the American Academy of Neurology (AAN 2022).





